WO0024750A1
|
|
Retinoid glycerol phospholipid conjugates
|
AU9218098A
|
|
Exocyclic-phosphoethanolamines
|
US6177476B1
|
|
Nutritional supplements for replenishing plasmalogens
|
US5883084A
|
|
Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine
|
US6022560A
|
|
Pharmaceutical compositions, novel uses, and novel form of α-tocopherylphosphocholine
|
AU7826198A
|
|
Pharmaceutical compositions containing alpha-tocopherylphosphocholine
|
WO9933851A1
|
|
N-het-substituted glycerophosphoethanolamines
|
CA2314885A1
|
|
Pharmaceutical compositions for mucolysis and treatment of inflammation
|
AU5463198A
|
|
Phosphoethanolamine conjugates of vitamin d compounds
|
US5891881A
|
|
Aminoheterocycle-substituted glycerols
|
US5776915A
|
|
Phosphocholines of retinoids
|
US5804569A
|
|
Exocylic-phosphoethanolamines
|
US5665714A
|
|
N-substituted glycerophosphoethanolamines
|
US5827836A
|
|
Retinoid glycerol phospholipid conjugates
|
US5703062A
|
|
N-het-substituted glycerophosphoethanolamines
|
US5730157A
|
|
Method for treating viral infection
|
US5661138A
|
|
(o-Acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines
|
US5691328A
|
|
Phosphoethanolamine conjugates of vitamin D compounds
|
US5698537A
|
|
Method of lowering the viscosity of mucus
|
AU5638096A
|
|
Non-biological patch for hemostasis
|